A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
BACKGROUND: Medicare Part B pharmaceutical spending has increased rapidly, more than doubling in 2006-2017. Yet, it is unclear whether this increase was driven by increased utilization or increased cost per claim. OBJECTIVE: To evaluate the relative impact of changes in drug utilization and cost per...
Main Authors: | Gellad, W.F (Author), Good, C.B (Author), Hernandez, I. (Author), San-Juan-Rodriguez, A. (Author), Shrank, W.H (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Managed Care Pharmacy (AMCP)
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Real-world evidence of a successful biosimilar adoption program
by: Humphreys, S.Z
Published: (2022) -
Switching Costs in the Market for Medicare Advantage Plans
by: Nosal, Kathleen Elizabeth
Published: (2012) -
The cost of excessive postoperative use of antimicrobials: the context of a public hospital
by: Rafael Santos Santana, et al. -
Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
by: Di Maria Jiang, et al.
Published: (2019-04-01) -
Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad
by: Tomas Ana, et al.
Published: (2016-01-01)